This document summarizes a presentation on using trichometry and cross-sectional trichometry (CST) to objectively measure hair loss and monitor treatment outcomes. CST allows clinicians to accurately track changes in hair mass index (HMI) over time to determine treatment effectiveness and progression of hair loss. The document provides examples of how CST can answer questions about treatment responses, compare different treatments, and distinguish shedding from permanent hair loss. CST provides a quantitative tool to optimize hair loss management.
THE ART of SKIN & BODY CARE by ASEPTA LABORATOIRES MONACOAsepta Laboratoires
INNOVATIVE & HIGHLY EFFECTIVE TARGETED PROFESSIONAL TREATMENTS for professional & home use - MADE IN MONACO by ASEPTA LABORATOIRES MONACO | The Laboratory Expert in Dermo-Pharmacy and Leader in Foot Care since 1943.
Discover the benefits of ASEPTA world renown brands: AKILEINE, CYCALEINE, ONYKOLEINE, AKILDIA, AKILWINTER, HELIABRINE, HELIXIENCE, HELIASLIM, COUP D'ECLAT, ECRINAL
Androgenetic Alopecia or hereditary hair loss, considered by many as an outward and undesirable sign of premature aging that can be ‘seen from across the room,’ currently affects an estimated 50 Million men and 30 Million women in the U.S. Approximately 40% of men in their 40’s are experiencing hair loss and 50% of men in their 50’s with over a billion dollars spent in the U.S. annually on medical treatments, hair transplants, non-medical ‘cures’ and cover-ups to address the condition.
Hormone replacement therapy (HRT) that includes androgens/testosterone may accelerate the progression of unwanted androgenetic alopecia, especially in those patients whose hair follicles are highly androgen sensitive.
OBJECTIVE: Patients who undergo testosterone replacement may be at risk for hair loss related side effects. It is our goal to present an overview of the mechanisms of Androgenetic Alopecia, new diagnostic and monitoring methods, prevention/treatments options and management stratagems specifically for patients who are undergoing an Hormone replacement therapy regimen that includes testosterone.
MATERIALS/METHODS:
Chief Complaint & Goals
Medical History
Family history
Medical Conditions
Medications
Surgical History
Hair/Scalp Care
Lab Testing / Measurements
Genetic Testing
Cross Sectional Bundle Trichometry Measurements with Hair Check(TM)
Photography
Standardized Global Photos
Scalp Microscopic Photos
Treatment Plan
Recommended Tracking & Follow-Up Schedule
DISCUSSION
Identifying patients at risk for hereditary hair loss as well as being able to offer guidance and treatment options holds significant benefit for the Age Management (Anti-Aging) Physician and their Hormone Replacement patients because it:
1) enhances the risk/benefit discussion with the testosterone patient.
2) Identifies and addresses a possible side-effect and potential barrier to HRT compliance.
3) Adds a beneficial service to the Age Management Physician’s repertoire that may enhance patient retention and compliance.
4) Successful hair loss management adds a psychological boost to a Androgen Replacement patient’s outlook.
References:
THE ART of SKIN & BODY CARE by ASEPTA LABORATOIRES MONACOAsepta Laboratoires
INNOVATIVE & HIGHLY EFFECTIVE TARGETED PROFESSIONAL TREATMENTS for professional & home use - MADE IN MONACO by ASEPTA LABORATOIRES MONACO | The Laboratory Expert in Dermo-Pharmacy and Leader in Foot Care since 1943.
Discover the benefits of ASEPTA world renown brands: AKILEINE, CYCALEINE, ONYKOLEINE, AKILDIA, AKILWINTER, HELIABRINE, HELIXIENCE, HELIASLIM, COUP D'ECLAT, ECRINAL
Androgenetic Alopecia or hereditary hair loss, considered by many as an outward and undesirable sign of premature aging that can be ‘seen from across the room,’ currently affects an estimated 50 Million men and 30 Million women in the U.S. Approximately 40% of men in their 40’s are experiencing hair loss and 50% of men in their 50’s with over a billion dollars spent in the U.S. annually on medical treatments, hair transplants, non-medical ‘cures’ and cover-ups to address the condition.
Hormone replacement therapy (HRT) that includes androgens/testosterone may accelerate the progression of unwanted androgenetic alopecia, especially in those patients whose hair follicles are highly androgen sensitive.
OBJECTIVE: Patients who undergo testosterone replacement may be at risk for hair loss related side effects. It is our goal to present an overview of the mechanisms of Androgenetic Alopecia, new diagnostic and monitoring methods, prevention/treatments options and management stratagems specifically for patients who are undergoing an Hormone replacement therapy regimen that includes testosterone.
MATERIALS/METHODS:
Chief Complaint & Goals
Medical History
Family history
Medical Conditions
Medications
Surgical History
Hair/Scalp Care
Lab Testing / Measurements
Genetic Testing
Cross Sectional Bundle Trichometry Measurements with Hair Check(TM)
Photography
Standardized Global Photos
Scalp Microscopic Photos
Treatment Plan
Recommended Tracking & Follow-Up Schedule
DISCUSSION
Identifying patients at risk for hereditary hair loss as well as being able to offer guidance and treatment options holds significant benefit for the Age Management (Anti-Aging) Physician and their Hormone Replacement patients because it:
1) enhances the risk/benefit discussion with the testosterone patient.
2) Identifies and addresses a possible side-effect and potential barrier to HRT compliance.
3) Adds a beneficial service to the Age Management Physician’s repertoire that may enhance patient retention and compliance.
4) Successful hair loss management adds a psychological boost to a Androgen Replacement patient’s outlook.
References:
For many, hair loss can be a devastating psychological condition. Unfortunately, dermatologists and primary doctors often fall short when it comes to the state-of-the-art diagnosis and treatment. It's up to hair restoration physicians and integrative practices to take the lead in the medical management of hair loss. Helping patients maintain, enhance and restore their own living and growing hair is a rewarding field to be in. Mismanaging patients expectations or therapies will certainly lead to disappointment. In this webinar, learn an overview of how we diagnose, measure, treat and track hair loss patients on various effective medical regimens. We often prescribe finasteride and FinPlus compounded finasteride, Formula82M minoxidil, LaserCap and in-office laser therapy, PRP with ECM BioD ACell, nutraceuticals and FUE NeoGraft hair transplantation. See some before and afters from various monotherapy patients. HairCheck cross sectional hair bundle trichometry is the key to keeping patients compliant. Thank you to LaserCap
Additional training is available from Dr. Alan J Bauman so visit http://www.haircoach.net for upcoming hands-on PRP and HairCheck classes.
Looking for reviews and ratings for hair transplant surgeon Dr. Alan Bauman?
For many years, Dr. Alan J. Bauman and Bauman Medical Group has used a robust patient feedback process to continually improve patient care in hair restoration and their treatment of hair loss patients. Aside from written feedback forms and surveys, Real Patient Ratings is a google-verified HIPAA-compliant 3rd-party electronic feedback system that allows actual patients of Dr. Alan Bauman to provide feedback, complaints, concerns and reviews regarding consultations, treatments, procedures, hair transplants, PRP as well as patient care and results. Dr. Alan Bauman and his team strive daily to provide exceptional results and patient care above and beyond the accepted norms in the industry.
Visit Real Patient Ratings for authentic reviews from real patients of board certified hair restoration doctor, Dr. Alan J. Bauman of Bauman Medical Group in Boca Raton, Florida.
Approach to a case of diffuse hair loss in females
. Anagen effluvium-
(a)Dystrophic
(b)Loose anagen hair
2. Telogen effluvium –
(a)acute telogen effluvium
(b)Chronic telogen effluvium
3. Female pattern hair loss
Primary CTE –represents a primary disorder and is a diagnosis of exclusion.
Secondary CTE- secondary to variety of systemic disorders.
Iron deficiency
Other deficiency –protein calorie malnutrition ,zinc deficiency
Thyroid diseases
Metabolic diseases-chronic liver or renal failure, advanced malignancy, pancreatic disease and upper GI disorder with malabsorption
SLE and other connective tissue disorders.
HIV infection
Drug induced
Lecture by Dr. Patrick Treacy from Ailesbury Hair Clinics to ICAD 2014 Brazil on the reasons and treatments for female hair loss. Courtesy given at lecture to some other doctors and clinics for some images used. Images related to Ailesbury Hair Clinics were added at a alter time.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
For many, hair loss can be a devastating psychological condition. Unfortunately, dermatologists and primary doctors often fall short when it comes to the state-of-the-art diagnosis and treatment. It's up to hair restoration physicians and integrative practices to take the lead in the medical management of hair loss. Helping patients maintain, enhance and restore their own living and growing hair is a rewarding field to be in. Mismanaging patients expectations or therapies will certainly lead to disappointment. In this webinar, learn an overview of how we diagnose, measure, treat and track hair loss patients on various effective medical regimens. We often prescribe finasteride and FinPlus compounded finasteride, Formula82M minoxidil, LaserCap and in-office laser therapy, PRP with ECM BioD ACell, nutraceuticals and FUE NeoGraft hair transplantation. See some before and afters from various monotherapy patients. HairCheck cross sectional hair bundle trichometry is the key to keeping patients compliant. Thank you to LaserCap
Additional training is available from Dr. Alan J Bauman so visit http://www.haircoach.net for upcoming hands-on PRP and HairCheck classes.
Looking for reviews and ratings for hair transplant surgeon Dr. Alan Bauman?
For many years, Dr. Alan J. Bauman and Bauman Medical Group has used a robust patient feedback process to continually improve patient care in hair restoration and their treatment of hair loss patients. Aside from written feedback forms and surveys, Real Patient Ratings is a google-verified HIPAA-compliant 3rd-party electronic feedback system that allows actual patients of Dr. Alan Bauman to provide feedback, complaints, concerns and reviews regarding consultations, treatments, procedures, hair transplants, PRP as well as patient care and results. Dr. Alan Bauman and his team strive daily to provide exceptional results and patient care above and beyond the accepted norms in the industry.
Visit Real Patient Ratings for authentic reviews from real patients of board certified hair restoration doctor, Dr. Alan J. Bauman of Bauman Medical Group in Boca Raton, Florida.
Approach to a case of diffuse hair loss in females
. Anagen effluvium-
(a)Dystrophic
(b)Loose anagen hair
2. Telogen effluvium –
(a)acute telogen effluvium
(b)Chronic telogen effluvium
3. Female pattern hair loss
Primary CTE –represents a primary disorder and is a diagnosis of exclusion.
Secondary CTE- secondary to variety of systemic disorders.
Iron deficiency
Other deficiency –protein calorie malnutrition ,zinc deficiency
Thyroid diseases
Metabolic diseases-chronic liver or renal failure, advanced malignancy, pancreatic disease and upper GI disorder with malabsorption
SLE and other connective tissue disorders.
HIV infection
Drug induced
Lecture by Dr. Patrick Treacy from Ailesbury Hair Clinics to ICAD 2014 Brazil on the reasons and treatments for female hair loss. Courtesy given at lecture to some other doctors and clinics for some images used. Images related to Ailesbury Hair Clinics were added at a alter time.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
1. CROSS SECTION
TRICHOMETRY
UPDATE
A NEW TOOL FOR MANAGING
PATIENTS WITH HAIR LOSS
ISHRS – ANNUAL SCIENTIFIC MEETING
Nassau, Bahamas – October 18-21, 2012
Bernard Cohen, MD
Diplomate, American Board of Dermatology
Diplomate, American Board of Hair Restoration Surgery
18. HMI
(BUNDLE CROSS SECTION)
will change if or when
A full-sized hair falls out
A miniaturized hair eventually vanishes
A full-sized hair emerges from the skin
A hair diameter increases
A hair diameter decreases
22. With CST you’ll be able to answer these questions:
How quickly is untreated AGA getting worse? What percent per year?
Is it time to advance my patient from MNX to FIN?
Does FIN work as well if taken 2x per week?
Is MNX 2% bid equivalent to MNX 5% daily?
Is generic MNX equivalent to Rogaine?
Is MNX more effective with added RetinA?
Do HairMax and LaserCap work better than MNX?
Is there an added benefit of adding MNX and/or laser to FIN?
If I correct a patient’s iron deficiency, does her shedding improve?
24. Questions that CST can easily answer:
How quickly is untreated AGA getting worse? What percent per year?
Should I advance my patient from MNX to FIN?
Does FIN work as well if taken 2x per week?
Is MNX 2% bid equivalent to MNX 5% daily?
Is generic MNX equivalent to Rogaine?
Is MNX more effective with added RetinA?
Do HairMax and LaserCap work better than MNX?
Is there an added benefit of adding MNX and/or laser to FIN?
If I correct a patient’s iron deficiency, does her shedding improve?
26. Questions that CST can easily answer:
How quickly is untreated AGA getting worse? What percent per year?
Is it time to advance my patient from MNX to FIN?
Does FIN work as well if taken 2x per week?
Is MNX 2% bid equivalent to MNX 5% daily?
Is generic MNX equivalent to Rogaine?
Is MNX more effective with added RetinA?
Do HairMax and LaserCap work better than MNX?
Is there an added benefit of adding MNX and/or laser to FIN?
If I correct a patient’s iron deficiency, does her shedding improve?
27. on FINASTERIDE 1mgm daily
reduce to1mgm 2x/wk
4963 62
Theoretical example – NOT clinical observation
One year later
28. Questions that CST can easily answer:
How quickly is untreated AGA getting worse? What percent per year?
Is it time to advance my patient from MNX to FIN?
Does FIN work as well if taken 2x per week?
Is MNX 2% bid equivalent to MNX 5% daily?
Is generic MNX equivalent to Rogaine?
Is MNX more effective with added RetinA?
Do HairMax and LaserCap work better than MNX?
Is there an added benefit of adding MNX and/or laser to FIN?
If I correct a patient’s iron deficiency, does her shedding improve?
29. MNX 2% bid x 1 year
Change to MNX 5% once
daily
4975 79
MNX 5% once daily
at end of following year
Theoretical example – NOT clinical observation
30. Questions that CST can easily answer:
How quickly is untreated AGA getting worse? What percent per year?
Is it time to advance my patient from MNX to FIN?
Does FIN work as well if taken 2x per week?
Is MNX 2% bid equivalent to MNX 5% daily?
Is generic MNX equivalent to Rogaine?
Is MNX more effective with added RetinA?
Do HairMax and LaserCap work better than MNX?
Is there an added benefit of adding MNX and/or laser to FIN?
If I correct a patient’s iron deficiency, does her shedding improve?
31. MNX 5% generic
at end of year #1
Switch to Rogaine 5%
4961 62
Rogaine 5%
at end of following year
Theoretical example – NOT clinical observation
32. Questions that CST can easily answer:
How quickly is untreated AGA getting worse? What percent per year?
Is it time to advance my patient from MNX to FIN?
Does FIN work as well if taken 2x per week?
Is MNX 2% bid equivalent to MNX 5% daily?
Is generic MNX equivalent to Rogaine?
Is MNX more effective with added RetinA?
Do HairMax and LaserCap work better than MNX?
Is there an added benefit of adding MNX and/or laser to FIN?
If I correct a patient’s iron deficiency, does her shedding improve?
34. Questions that CST can easily answer:
How quickly is untreated AGA getting worse? What percent per year?
Is it time to advance my patient from MNX to FIN?
Does FIN work as well if taken 2x per week?
Is MNX 2% bid equivalent to MNX 5% daily?
Is generic MNX equivalent to Rogaine?
Is MNX more effective with added RetinA?
Do HairMax and LaserCap work better than MNX?
Is there an added benefit of adding MNX and/or laser to FIN?
If I correct a patient’s iron deficiency, does her shedding improve?
35. On MNX 5% bid x 3 years
then switch patient
to Laser Rx
4963 61
24 MONTHS LATER
Theoretical example – NOT clinical observation
36. Questions that CST can easily answer:
How quickly is untreated AGA getting worse? What percent per year?
Is it time to advance my patient from MNX to FIN?
Does FIN work as well if taken 2x per week?
Is MNX 2% bid equivalent to MNX 5% daily?
Is generic MNX equivalent to Rogaine?
Is MNX more effective with added RetinA?
Do HairMax and LaserCap work better than MNX?
Is there an added benefit of adding MNX and/or laser to FIN?
If I correct a patient’s iron deficiency, does her shedding improve?
37. FIN 1mgm daily
4957 58
FIN 1 mgm daily
plus Laser Rx
Theoretical example – NOT clinical observation
38. Questions that CST can easily answer:
How quickly is untreated AGA getting worse? What percent per year?
Is it time to advance my patient from MNX to FIN?
Does FIN work as well if taken 2x per week?
Is MNX 2% bid equivalent to MNX 5% daily?
Is generic MNX equivalent to Rogaine?
Is MNX more effective with added RetinA?
Do HairMax and LaserCap work better than MNX?
Is there an added benefit of adding MNX and/or laser to FIN?
If I correct a patient’s iron deficiency, does her shedding improve?
40. Questions that CST can easily answer:
When has the woman with telogen effluvium stabilized?
My patient is convinced that MNX has made her “worse.”
How does FUE affect donor site density?
What percent improvement does my patient have after HT surgery?
Is this woman’s hair loss caused by shedding or AGA?
.
42. Questions that CST can easily answer:
When has the woman with telogen effluvium stabilized?
My patient is convinced that MNX has made her “worse.”
How does FUE affect donor site density?
What percent improvement does my patient have after HT surgery?
Is this woman’s hair loss caused by shedding or AGA?
.
43. Baseline HMI, then
4 months of MNX.
Phone call: “I’m much worse!”
4971 71
On re-exam
the next day
she is no worse.
44. Questions that CST can easily answer:
When has the woman with telogen effluvium stabilized?
My patient is convinced that MNX has made her “worse.”
How does FUE affect donor site density?
What percent improvement does my patient have after HT surgery?
Is this woman’s hair loss caused by shedding or AGA?
.
46. Questions that CST can easily answer:
When has the woman with telogen effluvium stabilized?
My patient is convinced that MNX has made her “worse.”
How does FUE affect donor site density?
What percent improvement does my patient have after HT surgery?
Is this woman’s hair loss caused by shedding or AGA?
.
48. Questions that CST can easily answer:
When has the woman with telogen effluvium stabilized?
My patient is convinced that MNX has made her “worse.”
How does FUE affect donor site density?
What percent improvement does my patient have after HT surgery?
Is this woman’s hair loss caused by shedding or AGA?
.